• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六点步态测试作为衡量多发性硬化症非卧床患者步行能力指标的效用

Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.

作者信息

Fritz Nora E, Jiang Allen, Keller Jennifer, Zackowski Kathleen M

机构信息

Kennedy Krieger Institute, Motion Analysis Laboratory, Baltimore, MD; Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD.

Kennedy Krieger Institute, Motion Analysis Laboratory, Baltimore, MD.

出版信息

Arch Phys Med Rehabil. 2016 Apr;97(4):507-512. doi: 10.1016/j.apmr.2015.10.100. Epub 2015 Nov 11.

DOI:10.1016/j.apmr.2015.10.100
PMID:26577146
Abstract

OBJECTIVE

To examine the concurrent validity of the Six-Spot Step Test (SSST) with clinical measures of walking and spatiotemporal measures of gait in multiple sclerosis (MS), and to understand the utility of the SSST in individuals with both low and high levels of disability.

DESIGN

Cross-sectional study.

SETTING

Laboratory.

PARTICIPANTS

Individuals with relapsing-remitting MS (N=29).

INTERVENTIONS

Not applicable.

MAIN OUTCOME MEASURES

In a single visit, demographic information (age, sex, Expanded Disability Status Scale [EDSS], symptom duration) and functional measures (SSST, timed Up and Go [TUG] test, timed 25-foot walk [T25FW] test, spatiotemporal measures of walking) were collected.

RESULTS

The SSST demonstrates concurrent validity with the TUG test, T25FW test, and 2-minute walk test (2MWT) (P≤.0002). Both spatial and temporal measures of gait are significantly related to SSST performance (P<.004). In individuals with lower disability (EDSS score 1-3.5), the SSST remains strongly related to the TUG test and T25FW test performances, whereas it fails to relate to any other measures. However, in the higher disability group (EDSS score 4-6), the SSST is significantly related to the TUG test, T25FW test, 2MWT, walk velocity, and both temporal and spatial measures of gait.

CONCLUSIONS

The SSST is an alternative test for lower-extremity function in the clinical setting that may useful in both higher and lower EDSS groups. The SSST requires minimal training to administer and may be a time-efficient measure of real-life functional performance that would be useful in large clinical trials.

摘要

目的

探讨六点步阶试验(SSST)与多发性硬化症(MS)患者步行的临床测量指标及步态时空测量指标之间的同时效度,并了解SSST在低残疾水平和高残疾水平个体中的效用。

设计

横断面研究。

地点

实验室。

参与者

复发缓解型MS患者(N = 29)。

干预措施

不适用。

主要观察指标

在单次就诊时,收集人口统计学信息(年龄、性别、扩展残疾状态量表[EDSS]、症状持续时间)和功能测量指标(SSST、计时起立行走试验[TUG]、25英尺计时步行试验[T25FW]、步行的时空测量指标)。

结果

SSST与TUG试验、T25FW试验及2分钟步行试验(2MWT)具有同时效度(P≤.0002)。步态的空间和时间测量指标均与SSST表现显著相关(P<.004)。在残疾程度较低(EDSS评分1 - 3.5)的个体中,SSST与TUG试验和T25FW试验表现仍密切相关,而与其他任何测量指标均无关联。然而,在高残疾组(EDSS评分4 - 6)中,SSST与TUG试验、T25FW试验、2MWT、步行速度以及步态的时间和空间测量指标均显著相关。

结论

SSST是临床环境中用于评估下肢功能的一种替代试验,在EDSS评分较高和较低的组中可能均有用。SSST实施所需的培训极少,可能是一种衡量现实生活功能表现的高效省时指标,在大型临床试验中会很有用。

相似文献

1
Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.六点步态测试作为衡量多发性硬化症非卧床患者步行能力指标的效用
Arch Phys Med Rehabil. 2016 Apr;97(4):507-512. doi: 10.1016/j.apmr.2015.10.100. Epub 2015 Nov 11.
2
Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis.六点步行试验作为评估多发性硬化症患者行走能力指标的进一步验证
Gait Posture. 2015 Jan;41(1):222-7. doi: 10.1016/j.gaitpost.2014.10.011. Epub 2014 Oct 23.
3
Evaluation of functional outcome measures after fampridine treatment in patients with multiple sclerosis - An interventional follow-up study.多发性硬化症患者服用氨吡啶治疗后功能结局指标的评估——一项干预性随访研究。
Mult Scler Relat Disord. 2022 Oct;66:104034. doi: 10.1016/j.msard.2022.104034. Epub 2022 Jul 5.
4
The six spot step test: a new measurement for walking ability in multiple sclerosis.六点步态测试:一种用于评估多发性硬化症患者步行能力的新测量方法。
Mult Scler. 2006 Aug;12(4):495-500. doi: 10.1191/1352458506ms1293oa.
5
Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.认知加工速度损伤不会影响多发性硬化症患者六步台阶测试表现的结构效度。
Phys Ther. 2021 Feb 4;101(2). doi: 10.1093/ptj/pzaa227.
6
Minimal detectable changes of the Berg Balance Scale, Fugl-Meyer Assessment Scale, Timed "Up & Go" Test, gait speeds, and 2-minute walk test in individuals with chronic stroke with different degrees of ankle plantarflexor tone.不同程度踝跖屈肌痉挛的慢性脑卒中患者 Berg 平衡量表、 Fugl-Meyer 评估量表、计时“站起-行走”测试、步态速度和 2 分钟步行测试的最小可检测变化。
Arch Phys Med Rehabil. 2012 Jul;93(7):1201-8. doi: 10.1016/j.apmr.2012.01.014. Epub 2012 Apr 12.
7
Validity of the Timed Up and Go Test as a Measure of Functional Mobility in Persons With Multiple Sclerosis.定时起立行走测试作为多发性硬化症患者功能活动能力衡量指标的有效性。
Arch Phys Med Rehabil. 2016 Jul;97(7):1072-7. doi: 10.1016/j.apmr.2015.12.031. Epub 2016 Mar 2.
8
Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.转身是多发性硬化症患者平衡信心和行走受限的重要标志。
PLoS One. 2018 Jun 7;13(6):e0198178. doi: 10.1371/journal.pone.0198178. eCollection 2018.
9
Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.比较多发性硬化症中定时 25 英尺和 100 米步行的表现测量。
Neurorehabil Neural Repair. 2011 Sep;25(7):672-9. doi: 10.1177/1545968310397204. Epub 2011 Mar 24.
10
How much does balance and muscle strength impact walking in persons with multiple sclerosis? - A cross-sectional study.平衡和肌肉力量对多发性硬化症患者行走的影响有多大? - 一项横断面研究。
Mult Scler Relat Disord. 2019 Apr;29:137-144. doi: 10.1016/j.msard.2019.01.034. Epub 2019 Jan 24.

引用本文的文献

1
Cerebellar Volume Measures Differentiate Multiple Sclerosis Fallers from Non-Fallers.小脑容积测量可区分多发性硬化症患者中的跌倒者与非跌倒者。
Brain Sci. 2025 Jan 16;15(1):77. doi: 10.3390/brainsci15010077.
2
Cerebellar volume measures may differentiate multiple sclerosis fallers from non-fallers.小脑容积测量可能有助于区分多发性硬化症患者中的跌倒者与非跌倒者。
Res Sq. 2024 Apr 19:rs.3.rs-4213155. doi: 10.21203/rs.3.rs-4213155/v1.
3
The six spot step test is superior in detecting walking capacity impairments compared to short- and long-distance walk tests in persons with multiple sclerosis.
与短距离和长距离步行测试相比,六点步态测试在检测多发性硬化症患者的步行能力损伤方面更具优势。
Mult Scler J Exp Transl Clin. 2023 Dec 12;9(4):20552173231218127. doi: 10.1177/20552173231218127. eCollection 2023 Oct-Dec.
4
The subjective minimal important change for the Six Spot Step Test in people with multiple sclerosis - The Danish MS Hospitals Rehabilitation study.多发性硬化症患者六分步测试的主观最小重要变化 - 丹麦多发性硬化症医院康复研究。
Acta Neurol Belg. 2022 Aug;122(4):893-901. doi: 10.1007/s13760-022-01991-4. Epub 2022 Jun 15.
5
Reliability and Validity of the Six Spot Step Test in People with Intellectual Disability.六点位阶梯测试在智障人群中的信度和效度
Brain Sci. 2021 Feb 6;11(2):201. doi: 10.3390/brainsci11020201.
6
Cognitive Processing Speed Impairment Does Not Influence the Construct Validity of Six-Spot Step Test Performance in People With Multiple Sclerosis.认知加工速度损伤不会影响多发性硬化症患者六步台阶测试表现的结构效度。
Phys Ther. 2021 Feb 4;101(2). doi: 10.1093/ptj/pzaa227.
7
H- P magnetic resonance spectroscopy: effect of biotin in multiple sclerosis.H- P 磁共振波谱:生物素对多发性硬化症的影响。
Ann Clin Transl Neurol. 2019 Jul;6(7):1332-1337. doi: 10.1002/acn3.50825. Epub 2019 Jun 27.